MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

COMPOSITION FOR GLUCOSE SENSING COMPRISING OF NANOFIBROUS MEMBRANE AND METHOD FOR MANUFACTURING NON-ENZYMATIC GLUCOSE BIOSENSOR USING THE SAME

Korea Health Industry Development Institute
Diabetes mellitus, a metabolic disease caused by deficiency of insulin, displays a higher or lower level of glucose concentration in blood than normal range(80-120mg/dL).

Mechanism of action

□ Excellent susceptibility, selectivity and stability , □ Providing simple and efficient methods for preparing a biosensor , □ Excellent reproducibility and commercializability

Full description

Technology Platform

The core technology of Kyungpook National University is to provide novel composition for glucose sensing comprising of nanofibrous membrane and method for manufacturing non-enzymatic glucose biosensor using the same.

Background and unmet needs: Most common technology for glucose analyzing in blood is enzyme-based method.  In spite of impressive development in electro-chemical glucose biosensors, highly stable and reliable glucose-sensing devices had been needed.  Enzyme-based glucose sensors have many problems such as instability of enzymes, oxygen-dependency and need of mediators.  Furthermore, low or high humidity could be dangerous in using the sensors.   Thus, there’s a need for non-enzymetic glucose sensing material.  Recently, present inventors proved the efficiency of non-enzymatic glucose sensing material based electrospinning nanofibrous. Nanofibrous showed excellent glucose sensing ability.  However, method of directly collecting electro-radiated PVdF/PAPBA (poly (vinylidene floride) /poly (aminophenyl boronic acid)) –NFM on ITO has difficulties in controlling thickness and uniformity of the surface.

Discovery and Achievements: For more simple and efficient way ofproducing non-enzymetic glucose using electro-emitted PVdF/PAPBA-NFM, the present inventors scattered electro-emitted PVdF/PAPBA-NFM in a solvent such as acetone, and plated above solvents to eletrode.

The present technology provides composition for detecting glucose comprising of material to be obtained by scattering electro-emitted PVdF/PAPBA-NFM in the solvent. The solvent may contain further additives.

The composion can be used availably by non-enzymetic glucose biosensor, and prepared by using the PVdF/PAPBA as active material for glucose sensing, which is active material for glucose sensing and verified the effects in the sensibility, alternative and stability in the inventor’ study before. More specifically, the PVdF/PAPBA may be contained at the rate of 90-99 wt% to 10-1 wt%. Also, because of using electrospun PVdF/PAPBA and having general caricteristics (for example, have high superficial area) of a nanofibrous membrane prepared by electro-irradiated process, the composition is profitable to application for biosensor.

The present technology provides further a preparation method for a electrospinning nanofibrous membrane, comprising the step of; (ⅰ) processing of preparing for nanofibrous membrane by electrospinning a mixture comprising of PVdF/PAPBA; (ⅱ) preparing of composition for detecting glucose by scattering electro-irradiated nanofibrous membrane obtained in step (ⅰ) into solusion; and (ⅲ) depositing composition for detecting glucose in step (ⅱ) on a electrode. The step (ⅰ) and (ⅱ) are a preparation process of the glucose-detecting composition which can be used directly through dissolved in a available solvent.

Key Features and Advantages:

(1) Excellent susceptibility, selectivity and stability

As the compounds of electro radiated PVdF/PAPBA maintain excellent susceptibility, selectivity and stability, they could be used in preparing biosensor efficiently. 

(2) Providing simple and efficient methods for preparing a biosensor

The method for preparing glucose biosensor of the present invention made an outstanding improvement on conventional PVdF/PAPBA method which is complicated and tangled process.

(3)Excellent reproducibility and commercializability

The method of the present invention provide a production process of excellent reproducibility and commercializability and make it possible to prepare more delicate and suitable biosensor due to great susceptibility, selectivity and stability .

                    (4) IP Position

These technologies have been filed for a patent application in a multitude of countries including Korea.

주요주주:

서춘길(22.37%), 한국기술투자(10.57%), TGV MMAA 벤처투자조합 등(5.46%)

0          250        500         750          1,000

The pending patent applications are anticipated to be patented in the near future.

 

 

 

Development status

Early Stage

Patent information

Country

Appln. No.

Status

Description

Korea

2008-0074282

Pending

Composition for glucose sensing comprising of nanofibrous membrane and method for manufacturing non-enzymatic glucose biosensor using the same

PCT

PCT/KR2008/006309

-

Composition for glucose sensing comprising of nanofibrous membrane and method for manufacturing non-enzymatic glucose biosensor using the same

Type of business relationship sought

development collaboration, or non-exclusive or exclusive licensing agreement

Company details

Korea Health Industry Development Institute

KHIDI, provides various services on technology transfer. KHIDI will license and commercialise several technologies of KHIDI's client companies via collaboration with overseas partners.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us